Entelexo Analysis: $125K Raised

What is Entelexo?

Entelexo develops exosome-based therapeutics targeting autoimmune diseases, utilizing engineered exosomes for communication with specific cell types.

Product Features & Capabilities

• engineered exosomes for autoimmune diseases, therapeutic exosome-based products, rapid prototyping of therapeutics, indication-specific exosome treatments, communication with multiple cell types

How much Entelexo raised

Who are the founders of Entelexo